SCAND1
gene geneOn this page
Also known as SDP1RAZ1
Summary
SCAND1 (SCAN domain containing 1, HGNC:10566) is a protein-coding gene on chromosome 20q11.23, encoding SCAN domain-containing protein 1 (P57086). May regulate transcriptional activity.
This gene encodes a SCAN box domain-containing protein. The SCAN domain is a highly conserved, leucine-rich motif of approximately 60 aa originally found within a subfamily of zinc finger proteins. This gene belongs to a family of genes that encode an isolated SCAN domain, but no zinc finger motif. This protein binds to and may regulate the function of the transcription factor myeloid zinc finger 1B. Alternate splicing results in multiple transcript variants.
Source: NCBI Gene 51282 — RefSeq curated summary.
At a glance
- GWAS associations: 4
- Clinical variants (ClinVar): 26 total
- GTEx eGene: eQTL in 19 tissues, sQTL in 0 (q < 0.05)
- Constraint (gnomAD): pLI 0.00 (LoF-tolerant), LOEUF 1.95 (unconstrained)
- MANE Select transcript:
NM_033630
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:10566 |
| Approved symbol | SCAND1 |
| Name | SCAN domain containing 1 |
| Location | 20q11.23 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | SDP1, RAZ1 |
| Ensembl gene | ENSG00000171222 |
| Ensembl biotype | protein_coding |
| OMIM | 610416 |
| Entrez | 51282 |
Gene structure
Transcript identifiers
Ensembl transcripts: 5 — 5 protein_coding
MANE Select: ENST00000305978
Transcript support level (Ensembl TSL; 1 = fully mRNA-supported): TSL 1: 2, TSL 5: 1
ENST00000305978, ENST00000373991, ENST00000615116, ENST00000857192, ENST00001133985
RefSeq mRNA: 3 — MANE Select: NM_033630
NM_001385710, NM_016558, NM_033630
CCDS: CCDS13269
Canonical transcript exons
ENST00000305978 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001210841 | 35954448 | 35954502 |
| ENSE00003913930 | 35953624 | 35954339 |
Expression profiles
Bgee: expression breadth ubiquitous, 278 present calls, max score 96.66.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 84.4713 / max 429.0524, expressed in 1825 samples.
Highest expression (Bgee): mucosa of transverse colon, olfactory segment of nasal mucosa, adrenal gland, adrenal gland cortex, adenohypophysis.
Genetic regulation across tissues (GTEx eQTL / sQTL)
SCAND1 is an eGene in GTEx v10 — its expression is genetically regulated (eQTL) in 19 tissues and its splicing (sQTL) in 0 (q < 0.05). Strongest associations first; slope = normalized effect of the lead variant’s alternative allele.
19 significant tissue × QTL associations:
| Tissue | QTL | q-value | Slope | Lead variant |
|---|---|---|---|---|
| Artery Aorta | eqtl | 1.3e-21 | +0.34 | 20:35944075:T:A |
| Cells Cultured fibroblasts | eqtl | 1.3e-15 | -0.27 | 20:35865440:T:A |
| Artery Tibial | eqtl | 4.5e-12 | +0.15 | 20:35932516:T:C |
| Cells EBV-transformed lymphocytes | eqtl | 1.4e-10 | -0.41 | 20:35967956:C:T |
| Whole Blood | eqtl | 6.0e-09 | -0.15 | 20:35959841:T:C |
| Lung | eqtl | 4.6e-05 | -0.18 | 20:35910629:T:C |
| Skin Not Sun Exposed Suprapubic | eqtl | 8.2e-05 | -0.14 | 20:35972604:G:A |
| Muscle Skeletal | eqtl | 1.2e-03 | +0.18 | 20:35958114:C:T |
| Pancreas | eqtl | 1.6e-03 | -0.21 | 20:35797042:C:G |
| Heart Left Ventricle | eqtl | 1.9e-03 | +0.24 | 20:35742661:G:C |
| Thyroid | eqtl | 5.3e-03 | -0.18 | 20:36627073:C:T |
| Adipose Visceral Omentum | eqtl | 6.6e-03 | -0.13 | 20:35967956:C:T |
| Brain Frontal Cortex BA9 | eqtl | 6.9e-03 | -0.42 | 20:36338300:G:A |
| Brain Nucleus accumbens basal ganglia | eqtl | 1.2e-02 | -0.19 | 20:35669362:G:T |
| Brain Cerebellar Hemisphere | eqtl | 1.6e-02 | -0.16 | 20:35949238:G:A |
| Brain Hippocampus | eqtl | 1.9e-02 | -0.58 | 20:36955601:C:T |
| Brain Anterior cingulate cortex BA24 | eqtl | 2.0e-02 | -0.19 | 20:35578178:G:C |
| Skin Sun Exposed Lower leg | eqtl | 3.8e-02 | -0.13 | 20:36677463:G:A |
| Adipose Subcutaneous | eqtl | 4.6e-02 | +0.24 | 20:35475050:T:C |
FANTOM5 promoters
8 alternative TSS:
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 187101 | 41.4926 | 1821 |
| 187099 | 37.2198 | 1818 |
| 187098 | 2.2224 | 1170 |
| 187102 | 1.6675 | 1127 |
| 187103 | 0.7225 | 458 |
| 187100 | 0.7189 | 437 |
| 187104 | 0.3922 | 56 |
| 187097 | 0.0355 | 6 |
Top tissues by expression
showing 100 of 291 tissues by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| mucosa of transverse colon | UBERON:0004991 | 96.66 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 96.61 | gold quality |
| right adrenal gland | UBERON:0001233 | 95.77 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 95.60 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 95.56 | gold quality |
| left adrenal gland | UBERON:0001234 | 95.51 | gold quality |
| adenohypophysis | UBERON:0002196 | 95.45 | gold quality |
| right lobe of liver | UBERON:0001114 | 95.33 | gold quality |
| apex of heart | UBERON:0002098 | 95.04 | gold quality |
| right uterine tube | UBERON:0001302 | 95.01 | gold quality |
| adrenal cortex | UBERON:0001235 | 94.97 | gold quality |
| metanephros cortex | UBERON:0010533 | 94.73 | gold quality |
| mucosa of stomach | UBERON:0001199 | 94.68 | gold quality |
| granulocyte | CL:0000094 | 94.53 | gold quality |
| left coronary artery | UBERON:0001626 | 94.44 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 94.38 | gold quality |
| lower esophagus | UBERON:0013473 | 94.26 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 94.26 | gold quality |
| body of stomach | UBERON:0001161 | 94.21 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 94.20 | gold quality |
| pituitary gland | UBERON:0000007 | 94.12 | gold quality |
| coronary artery | UBERON:0001621 | 94.11 | gold quality |
| left uterine tube | UBERON:0001303 | 94.04 | gold quality |
| ascending aorta | UBERON:0001496 | 94.02 | gold quality |
| thoracic aorta | UBERON:0001515 | 94.01 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 93.97 | gold quality |
| cingulate cortex | UBERON:0003027 | 93.90 | gold quality |
| monocyte | CL:0000576 | 93.80 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 93.77 | gold quality |
| transverse colon | UBERON:0001157 | 93.69 | gold quality |
| body of pancreas | UBERON:0001150 | 93.65 | gold quality |
| omental fat pad | UBERON:0010414 | 93.65 | gold quality |
| mononuclear cell | CL:0000842 | 93.63 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 93.62 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 93.62 | gold quality |
| spleen | UBERON:0002106 | 93.59 | gold quality |
| peritoneum | UBERON:0002358 | 93.59 | gold quality |
| leukocyte | CL:0000738 | 93.53 | gold quality |
| aorta | UBERON:0000947 | 93.50 | gold quality |
| skin of abdomen | UBERON:0001416 | 93.50 | gold quality |
| amygdala | UBERON:0001876 | 93.49 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 93.47 | gold quality |
| adipose tissue of abdominal region | UBERON:0007808 | 93.44 | gold quality |
| gastrocnemius | UBERON:0001388 | 93.39 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 93.39 | gold quality |
| putamen | UBERON:0001874 | 93.38 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 93.37 | gold quality |
| endocervix | UBERON:0000458 | 93.36 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 93.36 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 93.34 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 93.29 | gold quality |
| right ovary | UBERON:0002118 | 93.26 | gold quality |
| minor salivary gland | UBERON:0001830 | 93.25 | gold quality |
| popliteal artery | UBERON:0002250 | 93.21 | gold quality |
| skin of leg | UBERON:0001511 | 93.20 | gold quality |
| caudate nucleus | UBERON:0001873 | 93.20 | gold quality |
| tibial artery | UBERON:0007610 | 93.20 | gold quality |
| left ovary | UBERON:0002119 | 93.19 | gold quality |
| nucleus accumbens | UBERON:0001882 | 93.18 | gold quality |
| nasal cavity mucosa | UBERON:0001826 | 93.16 | gold quality |
| ectocervix | UBERON:0012249 | 93.05 | gold quality |
| right atrium auricular region | UBERON:0006631 | 93.02 | gold quality |
| right frontal lobe | UBERON:0002810 | 92.94 | gold quality |
| prefrontal cortex | UBERON:0000451 | 92.91 | gold quality |
| body of uterus | UBERON:0009853 | 92.88 | gold quality |
| mouth mucosa | UBERON:0003729 | 92.86 | gold quality |
| right testis | UBERON:0004534 | 92.83 | gold quality |
| esophagus | UBERON:0001043 | 92.73 | gold quality |
| right coronary artery | UBERON:0001625 | 92.57 | gold quality |
| spinal cord | UBERON:0002240 | 92.54 | gold quality |
| right lung | UBERON:0002167 | 92.49 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 92.47 | gold quality |
| adrenal gland | UBERON:0002369 | 92.46 | gold quality |
| esophagus mucosa | UBERON:0002469 | 92.40 | gold quality |
| left testis | UBERON:0004533 | 92.38 | gold quality |
| corpus epididymis | UBERON:0004359 | 92.27 | gold quality |
| heart left ventricle | UBERON:0002084 | 92.24 | gold quality |
| thyroid gland | UBERON:0002046 | 92.16 | gold quality |
| cardiac ventricle | UBERON:0002082 | 92.01 | gold quality |
| tibial nerve | UBERON:0001323 | 91.97 | gold quality |
| hypothalamus | UBERON:0001898 | 91.97 | gold quality |
| zone of skin | UBERON:0000014 | 91.93 | gold quality |
| small intestine | UBERON:0002108 | 91.90 | gold quality |
| adipose tissue | UBERON:0001013 | 91.78 | gold quality |
| gingiva | UBERON:0001828 | 91.77 | gold quality |
| saliva-secreting gland | UBERON:0001044 | 91.75 | gold quality |
| subcutaneous adipose tissue | UBERON:0002190 | 91.71 | gold quality |
| palpebral conjunctiva | UBERON:0001812 | 91.67 | gold quality |
| colon | UBERON:0001155 | 91.66 | gold quality |
| neocortex | UBERON:0001950 | 91.63 | gold quality |
| muscle of leg | UBERON:0001383 | 91.56 | gold quality |
| fundus of stomach | UBERON:0001160 | 91.42 | gold quality |
| liver | UBERON:0002107 | 91.40 | gold quality |
| forebrain | UBERON:0001890 | 91.33 | gold quality |
| frontal cortex | UBERON:0001870 | 91.32 | gold quality |
| frontal lobe | UBERON:0016525 | 91.32 | gold quality |
| upper lobe of lung | UBERON:0008948 | 91.27 | gold quality |
| large intestine | UBERON:0000059 | 91.23 | gold quality |
| upper lobe of left lung | UBERON:0008952 | 91.22 | gold quality |
| epithelium of bronchus | UBERON:0002031 | 91.20 | gold quality |
Single-cell (SCXA)
Detected in 5 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-HCAD-29 | no | 134.26 |
| E-CURD-120 | no | 28.95 |
| E-MTAB-8410 | no | 3.59 |
| E-GEOD-125970 | no | 3.09 |
| E-ANND-3 | no | 0.00 |
HPA expression
RNA tissue specificity: Low tissue specificity
showing 60 of 76 HPA tissues / cells by nTPM:
| Tissue / cell | Axis | nTPM |
|---|---|---|
| Pituitary gland | tissue | 84.0 |
| Choroid plexus | tissue | 79.9 |
| Hippocampal formation | tissue | 78.6 |
| Superior colliculi | tissue | 78.3 |
| Thalamus | tissue | 76.2 |
| Pons | tissue | 75.8 |
| Cerebral cortex | tissue | 68.4 |
| Somatosensory cortex | tissue | 68.4 |
| Hypothalamus | tissue | 68.0 |
| Basal ganglia | tissue | 65.3 |
| Locus coeruleus | tissue | 64.3 |
| Midbrain | tissue | 63.7 |
| Motor cortex | tissue | 62.8 |
| Occipital cortex | tissue | 62.4 |
| Medulla oblongata | tissue | 61.8 |
| Septum | tissue | 61.6 |
| Hippocampus | tissue | 60.9 |
| Putamen | tissue | 60.3 |
| Spinal cord | tissue | 59.3 |
| Substantia nigra | tissue | 59.0 |
| Prefrontal cortex | tissue | 57.6 |
| Vagina | tissue | 57.1 |
| Nucleus accumbens | tissue | 56.5 |
| Ventral forebrain | tissue | 56.3 |
| Retrosplenial and cingulate cortex | tissue | 55.0 |
| Temporal cortex | tissue | 55.0 |
| Entorhinal cortex | tissue | 54.3 |
| Periaqueductal gray | tissue | 53.5 |
| Postcentral gyrus | tissue | 53.4 |
| Retrosplenial cortex | tissue | 52.8 |
| Cerebellum | tissue | 51.7 |
| Insular cortex | tissue | 48.6 |
| Amygdala | tissue | 47.7 |
| Olfactory bulb | tissue | 47.6 |
| Bone marrow | tissue | 41.8 |
| Skeletal muscle | tissue | 40.8 |
| Duodenum | tissue | 33.3 |
| Corpus callosum | tissue | 32.5 |
| Stomach 1 | tissue | 30.6 |
| Adipose tissue | tissue | 29.3 |
| Salivary gland | tissue | 26.4 |
| Small intestine | tissue | 26.2 |
| Spleen | tissue | 24.5 |
| Pancreas | tissue | 22.2 |
| Adrenal gland | tissue | 21.7 |
| Liver | tissue | 20.6 |
| Kidney | tissue | 20.3 |
| Colon | tissue | 19.8 |
| Appendix | tissue | 19.0 |
| Prostate | tissue | 18.8 |
| Ovary | tissue | 14.9 |
| Skin 1 | tissue | 13.6 |
| Lymph node | tissue | 12.9 |
| Lung | tissue | 12.2 |
| Seminal vesicle | tissue | 10.5 |
| Endometrium 1 | tissue | 10.2 |
| Thymus | tissue | 9.6 |
| Parathyroid gland | tissue | 9.1 |
| Placenta | tissue | 8.9 |
| Testis | tissue | 8.8 |
Brain sub-regions (HPA Brain Atlas): detected in 189; highest nTPM — Nucleus ambiguus (91.3), Blood vessel (82.5), Ventral hippocampus (78.6), Lateral hypothalamic area (75.1), Dorsal hippocampus (73.0).
Regulation
Is transcription factor: yes
Downstream targets (CollecTRI)
1 targets:
| Target | Regulation |
|---|---|
| ZNF202 | Unknown |
miRNA regulators (miRDB)
Targeting SCAND1 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific).
1 miRNAs:
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-335-3P | 99.93 | 73.36 | 4958 |
Functional genomics
gnomAD constraint: pLI 0.00108, LOEUF 1.95, missense Z -2.06 — population loss-of-function intolerance (pLI ≥ 0.9 = LoF-intolerant; lower LOEUF = more constrained). gnomAD
Regional missense constraint (gnomAD RMC): no regional variation along ENST00000305978 — one region, missense o/e 1.17.
Literature-anchored findings (GeneRIF, showing 2)
- This result indicates that NY-REN-21 can function either as a homodimer or as a heterodimer with SCAND1. (PMID:16540086)
- SCAND1 Reverses Epithelial-to-Mesenchymal Transition (EMT) and Suppresses Prostate Cancer Growth and Migration. (PMID:36552758)
Cross-species orthologs
11 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | plagx | ENSDARG00000036855 |
| danio_rerio | ovol1a | ENSDARG00000076472 |
| danio_rerio | plagl2 | ENSDARG00000076657 |
| danio_rerio | ovol1b | ENSDARG00000078256 |
| mus_musculus | Scand1 | ENSMUSG00000046229 |
| rattus_norvegicus | Scand1 | ENSRNOG00000019987 |
| drosophila_melanogaster | hb | FBGN0001180 |
| drosophila_melanogaster | CG12391 | FBGN0033581 |
| caenorhabditis_elegans | WBGENE00001824 | |
| caenorhabditis_elegans | WBGENE00003033 | |
| caenorhabditis_elegans | WBGENE00012385 |
Paralogs (29): ZNF446 (ENSG00000083838), REST (ENSG00000084093), ZNF174 (ENSG00000103343), OVOL3 (ENSG00000105261), PLAGL1 (ENSG00000118495), ZSCAN18 (ENSG00000121413), ZNF576 (ENSG00000124444), OVOL2 (ENSG00000125850), PLAGL2 (ENSG00000126003), ZSCAN5A (ENSG00000131848), ZSCAN29 (ENSG00000140265), ZSCAN32 (ENSG00000140987), ZSCAN1 (ENSG00000152467), ZNF18 (ENSG00000154957), ZKSCAN2 (ENSG00000155592), ZNF496 (ENSG00000162714), ZNF202 (ENSG00000166261), ZNF641 (ENSG00000167528), ZNF444 (ENSG00000167685), ZNF274 (ENSG00000171606), ZNF131 (ENSG00000172262), OVOL1 (ENSG00000172818), ZNF518A (ENSG00000177853), ZNF518B (ENSG00000178163), PLAG1 (ENSG00000181690), ZSCAN5B (ENSG00000197213), ZNF770 (ENSG00000198146), PEG3 (ENSG00000198300), ZSCAN5C (ENSG00000204532)
Mouse-model phenotypes
Observed phenotypes of the mouse ortholog (MGI:1343132) from MGI (Alliance of Genome Resources) — knockout/mutant phenotypes, ranked by annotation count. 3 distinct phenotype terms.
| Mouse phenotype (MP) | Records |
|---|---|
| hyperactivity | 1 |
| increased circulating creatinine level | 1 |
| decreased red blood cell distribution width | 1 |
Additional cross-species homologs
Sequence homologs in species beyond Ensembl Compara’s model organisms, by Diamond local protein alignment (% sequence identity; best hit per species). Lower-identity rows are more distant homologs. The matched accessions’ gene symbols aren’t in biobtree yet, so each row shows the UniProt accession.
| Organism | UniProt | Identity | Method |
|---|---|---|---|
| Gorilla gorilla gorilla | A1YEW3 | 100.0% | Diamond |
| Pan paniscus | A1YG31 | 100.0% | Diamond |
| Pan troglodytes | A2T715 | 100.0% | Diamond |
| Pongo pygmaeus | A2T7M0 | 89.4% | Diamond |
| Bos taurus | Q32PG5 | 71.9% | Diamond |
Genomic neighbors (locus context)
Genes flanking this one on the chromosome (NCBI/Entrez gene neighborhood). Positional context only — some neighbors share regulatory elements (bidirectional promoters, antisense/overlapping transcripts), but chromosomal adjacency is not itself a functional relationship (see Interactions for that).
| Symbol | Type | Entrez |
|---|---|---|
| CNBD2 | protein-coding | 140894 |
| PHF20 | protein-coding | 51230 |
| NORAD | ncRNA | 647979 |
| EPB41L1 | protein-coding | 2036 |
Protein
Protein identifiers
SCAN domain-containing protein 1 — P57086 (reviewed: P57086)
All UniProt accessions (1): P57086
UniProt curated annotations — full annotation on UniProt →
Function. May regulate transcriptional activity.
Subunit / interactions. Interacts with ZNF202.
Subcellular location. Nucleus.
RefSeq proteins (3): NP_001372639, NP_057642, NP_361012* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR003309 | SCAN_dom | Domain |
| IPR038269 | SCAN_sf | Homologous_superfamily |
| IPR050916 | SCAN-C2H2_zinc_finger | Family |
Pfam: PF02023
UniProt features (4 total): chain 1, domain 1, region of interest 1, compositionally biased region 1
Structure
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-P57086-F1 | 72.37 | 0.34 |
Human Protein Atlas
Protein class: Predicted intracellular proteins, Plasma proteins
Protein evidence: Evidence at protein level
Subcellular location (HPA, imaging): nuclear speckles
Antibody reliability (HPA): IF approved
Function
Pathways and Gene Ontology
Reactome pathways
0 curated (TAS) of 0; 0 disease pathways. Curated-first; evidence = TAS (manually curated) vs IEA (electronic inference).
MSigDB gene sets: 96 (showing top):
BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN, NIKOLSKY_BREAST_CANCER_20Q11_AMPLICON, STARK_PREFRONTAL_CORTEX_22Q11_DELETION_DN, AREB6_01, HUMMERICH_MALIGNANT_SKIN_TUMOR_DN, SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN, MODULE_123, SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP, MODULE_98, chr20q11, DANG_BOUND_BY_MYC, MODULE_114, BENPORATH_MYC_MAX_TARGETS, LU_EZH2_TARGETS_UP, HUANG_GATA2_TARGETS_UP
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (1): nucleus (GO:0005634)
GO top-level categories
2 GO namespaces:
| Category | Terms |
|---|---|
| binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Experimentally-supported GO annotations
GO terms backed by direct experimental evidence (ECO experimental codes) — 1 of 2 annotations. The rest are phylogenetic / computational / electronic (IEA).
1 experimentally-supported GO terms:
| GO term | NS | Evidence |
|---|---|---|
| nucleus | CC | direct assay |
Protein interactions and networks
STRING
showing 15 of 1,040 interactions by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| SCAND1 | ZSCAN2 | Q7Z7L9 | 551 |
| SCAND1 | CNBD2 | Q96M20 | 498 |
| SCAND1 | HSF5 | Q4G112 | 456 |
| SCAND1 | ZNF322 | Q6U7Q0 | 444 |
| SCAND1 | WDR73 | Q6P4I2 | 439 |
| SCAND1 | THNSL1 | Q8IYQ7 | 439 |
| SCAND1 | CCDC85B | Q15834 | 414 |
| SCAND1 | DENND11 | A4D1U4 | 403 |
| SCAND1 | CDC37 | Q16543 | 397 |
| SCAND1 | RADIL | Q96JH8 | 383 |
| SCAND1 | UTP3 | Q9NQZ2 | 375 |
| SCAND1 | MIEN1 | Q9BRT3 | 374 |
| SCAND1 | HSPA4L | O95757 | 370 |
| SCAND1 | HSPA4 | P34932 | 370 |
| SCAND1 | HSPA13 | P48723 | 366 |
IntAct
Human interaction partners of SCAND1 in IntAct, one row per partner (best MIscore; records = supporting IntAct interaction records).
showing 30 of 57 partners by confidence:
| Partner | Interaction type | MIscore | Records |
|---|---|---|---|
| PGBD1 | physical association | 0.940 | 11 |
| ZKSCAN4 | physical association | 0.870 | 7 |
| ZNF24 | physical association | 0.850 | 6 |
| ZNF263 | physical association | 0.800 | 4 |
| ZSCAN22 | physical association | 0.760 | 7 |
| ZSCAN32 | physical association | 0.750 | 2 |
| ZNF394 | association | 0.740 | 12 |
| ZNF397 | physical association | 0.740 | 5 |
| ZSCAN18 | physical association | 0.740 | 4 |
| ZNF449 | physical association | 0.720 | 8 |
| GORASP2 | physical association | 0.720 | 6 |
| ZNF165 | physical association | 0.670 | 11 |
| ZKSCAN7 | physical association | 0.670 | 10 |
| ZSCAN23 | physical association | 0.670 | 8 |
| ZNF396 | physical association | 0.670 | 5 |
| ZNF213 | physical association | 0.670 | 3 |
| ZNF496 | physical association | 0.670 | 3 |
| ZNF202 | physical association | 0.660 | 2 |
| ZNF446 | physical association | 0.560 | 5 |
| ZSCAN12 | physical association | 0.560 | 5 |
| AGTRAP | physical association | 0.560 | 3 |
| APH1A | physical association | 0.560 | 3 |
| CALCOCO2 | physical association | 0.560 | 3 |
| CCDC51 | physical association | 0.560 | 3 |
| DGAT2L6 | physical association | 0.560 | 3 |
| GOLGA6L9 | physical association | 0.560 | 3 |
| KRT40 | physical association | 0.560 | 3 |
| LHX4 | physical association | 0.560 | 3 |
| NDUFB5 | physical association | 0.560 | 3 |
| PICK1 | physical association | 0.560 | 3 |
BioGRID (118 interactions; top human partners by supporting records): PGBD1 (Two-hybrid; 5 records), ZNF24 (Affinity Capture-MS; 5 records), ZNF263 (Two-hybrid; 5 records), ZNF397 (Affinity Capture-MS; 5 records), ZSCAN32 (Affinity Capture-MS; 5 records), ZKSCAN4 (Two-hybrid; 4 records), ZNF396 (Affinity Capture-MS; 4 records), ZSCAN20 (Affinity Capture-MS; 4 records), MZF1 (Two-hybrid; 3 records), ZKSCAN7 (Two-hybrid; 3 records), ZNF394 (Affinity Capture-MS; 3 records), ZNF444 (Affinity Capture-MS; 3 records), ZNF483 (Affinity Capture-MS; 3 records), ZSCAN22 (Affinity Capture-MS; 3 records), GORASP2 (Two-hybrid; 2 records)
SIGNOR signaling
1 signaling interactions:
| A | Effect | B | Mechanism |
|---|---|---|---|
| SCAND1 | “up-regulates activity” | MZF1 | binding |
Disease & clinical
Genetic variants
Variant evidence for SCAND1: 26 ClinVar records (0 pathogenic / likely pathogenic); 4 GWAS associations.
ClinVar
26 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 25 |
| Likely benign | 1 |
| Benign | 0 |
SpliceAI
Top 10 splice-impact sites by Δscore (adjacent positions with the same effect merged into one range; 19 predictions of 54):
| Position(s) | Effect | Δscore | Sites |
|---|---|---|---|
| 20:35954446–35954447 | donor_loss | 0.9400 | 5 |
| 20:35954446 | donor_loss | 0.8700 | |
| 20:35954350 | acceptor_gain | 0.8200 | |
| 20:35954375 | acceptor_gain | 0.7400 | |
| 20:35954346 | acceptor_gain | 0.7300 | |
| 20:35954340–35954341 | acceptor_loss | 0.7200 | 6 |
| 20:35954355 | acceptor_gain | 0.6600 | |
| 20:35954448 | donor_loss | 0.6500 | |
| 20:35954342 | acceptor_loss | 0.6400 | |
| 20:35954445 | donor_loss | 0.6200 |
HPA cancer prognostics
RNA cancer specificity: Low cancer specificity
Human Protein Atlas survival analysis — favorable = higher expression predicts better survival.
1 prognostic cancer types:
| Cancer | Prognostic | p-value |
|---|---|---|
| Pancreatic Adenocarcinoma (TCGA) | favorable | 0.000932 |
Disease associations
OMIM: gene MIM:610416 | disease phenotypes:
GWAS associations
4 associations:
| Study | Trait | p-value |
|---|---|---|
| GCST010002_341 | Refractive error | 2e-20 |
| GCST004067_150 | Hip circumference adjusted for BMI | 6e-12 |
| GCST004067_196 | Hip circumference adjusted for BMI | 1e-7 |
| GCST004067_31 | Hip circumference adjusted for BMI | 8e-7 |
EFO canonical traits (from GWAS)
1 canonical traits:
| EFO ID | Trait name |
|---|---|
| EFO:0008039 | BMI-adjusted hip circumference |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (CPIC guideline: no)
CTD chemical–gene interactions
23 total (human), top 23 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| sodium arsenite | decreases expression | 2 |
| Air Pollutants | decreases expression, affects expression, increases abundance | 2 |
| Estradiol | affects binding, increases reaction, decreases expression | 2 |
| triphenyl phosphate | affects expression | 1 |
| arsenite | increases reaction, affects binding | 1 |
| ICG 001 | decreases expression | 1 |
| abrine | increases expression | 1 |
| (+)-JQ1 compound | decreases expression | 1 |
| MT19c compound | decreases expression | 1 |
| Decitabine | increases expression | 1 |
| Caffeine | increases phosphorylation | 1 |
| Dimethylnitrosamine | decreases expression | 1 |
| Hydrogen Peroxide | affects expression | 1 |
| Methotrexate | decreases expression | 1 |
| Ozone | affects expression, increases abundance | 1 |
| Smoke | decreases expression | 1 |
| Valproic Acid | increases expression | 1 |
| 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | increases expression | 1 |
| Sodium Selenite | increases expression | 1 |
| Copper Sulfate | decreases expression | 1 |
| Phenol | decreases expression | 1 |
| Vitamin K 3 | affects expression | 1 |
| Particulate Matter | decreases expression, increases abundance | 1 |
Cellosaurus cell lines
1 cell lines: 1 cancer cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_B2EN | Abcam HeLa SCAND1 KO | Cancer cell line | Female |
Clinical trials (associated diseases)
Via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.